Florida Pharmaceutical Products, Inc., and Quinn Pharmaceuticals, LLC Announce Strategic Alliance

Monday, February 4, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

Florida Pharmaceutical Products, Inc. (FPP) and Quinn Pharmaceuticals, LLC, announced their strategic alliance to create an end-to-end solution for generic pharmaceutical development, manufacture, sales, marketing distribution and supply chain logistics.

BOCA RATON, Fla. and IRVINE, Calif., Feb. 04, 2019 /PRNewswire-PRWeb/ -- Deal Combines

Strengths of Both Companies Creating End-To-End Solution From Procurement to Order Fulfillment; Capitalizing On Opportunities Originating in Asia For U.S. Distribution

Stason Pharmaceuticals, Inc., a global pharmaceutical group based in Irvine, CA has entered into a strategic alliance with Florida Pharmaceutical Products, Inc., (FPP) for Stason subsidiary Quinn Pharmaceuticals, LLC. Financial terms were not disclosed.

With strong business ties to pharmaceutical interests in Japan, Taiwan and China, Stason Pharmaceuticals, Inc., acquires and develops promising drug candidates originating in Asia and guides their manufacture, sale and distribution within the United States.

Florida Pharmaceutical Products, Inc., based in Boca Raton, FL has experienced leadership with proven deal-closing expertise, a solid implementation track record, influential industry relationships and extensive resources to realize objectives with speed and efficiency.

According to Florida Pharmaceutical Products, Inc., President Larry Lapila, "The structure of this agreement supercharges the flow of generic pharmaceutical drugs from Asia to the United States and utilizes our skillset to create greater production, distribution and supply chain efficiencies for Stason and Quinn."

Stason Pharmaceuticals, Inc., CEO Harry Fan adds, "The Quinn label, built by the Quinn team under the leadership of Gina Campbell, is recognized for quality and value. The new alliance with Florida Pharmaceutical Products, Inc., creates a continuous all-inclusive solution by fueling manufacturing options and also adding warehousing, logistics and order fulfillment to retail accounts. This framework improves results and provides the infrastructure for continued growth."

This new arrangement merges capabilities to create an end-to-end solution for generic pharmaceutical development, manufacture, sales, marketing, distribution and supply chain logistics.

Florida Pharmaceutical Products, Inc., recently entered a strategic partnership with Woodfield Distribution, LLC to support FPP business expansion.

For further information, contact Larry Lapila, Florida Pharmaceutical Products, Inc., or Gina Campbell, Quinn Pharmaceuticals, Inc., (561) 609-3240 or info@flpharmaproducts.com.

 

SOURCE Florida Pharmaceutical Products, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store